Evaluation of the impact of repeated intravenous phage doses on mammalian host–phage interactions
Journal of Virology · 2024
DOI: 10.1128/jvi.01359-23 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Virology, 2024. Verfasst von Xin Tan und 15 weiteren Autor:innen. Beteiligte Einrichtung: Key Laboratory of Quantitative Synthetic Biology, Shenzhen Institute of Synthetic Biology, Shenzhen Institutes of Advanced Technology, Chinese Academ…. Hauptthemen laut MEDLINE: Bacterial Infections, Bacteriophages, Phage Therapy. Die Arbeit wurde bisher 42-mal zitiert (Crossref) und nennt 43 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: The Ministry of Science and Technology of China, National Key R&D Program of China, Shenzhen Medical Academy of Research and Translation fundings, Shenzhen Institute of Synthetic Biology Scientific Research Program.
Abstract (Originalsprache)
Phage therapy has shown great promise for the treatment of multidrug-resistant bacterial infections. However, the lack of a thorough and organized understanding of phage–body interactions has limited its clinical application. Here, we administered different purified phages ( Salmonella phage SE_SZW1, Acinetobacter phage AB_SZ6, and Pseudomonas phage PA_LZ7) intravenously to healthy animals (rats and monkeys) to evaluate the phage-induced host responses and phage pharmacokinetics with different intravenous (IV) doses in healthy animals. The plasma and the organs were sampled after different IV doses to determine the phage biodistribution, phage-induced cytokines, and antibodies. The potential side effects of phages on animals were assessed. A non-compartment model revealed that the plasma phage titer gradually decreased over time following a single dose. Repeated doses resulted in a 2–3 Log 10 decline of the plasma phage titer at 5 min compared to the first dose, regardless of the type of phage administered in rats. Host innate immune responses were activated including splenic enlargement following repeated doses. Phage-specific neutralization antibodies in animals receiving phages were detected. Similar results were obtained from monkeys. In conclusion, the mammalian bodies were well-tolerant to the administered phages. The animal responses to the phages and the phage biodistribution profiles could have a significant impact on the efficacy of phage therapy. IMPORTANCE Phage therapy has demonstrated potential in addressing multidrug-resistant bacterial infections. However, an insufficient understanding of phage–host interactions has impeded its broader clinical application. In our study, specific phages were administered intravenously (IV) to both rats and monkeys to elucidate phage–host interactions and evaluate phage pharmacokinetics (PK). Results revealed that with successive IV administrations, there was a decrease in plasma phage concentrations. Concurrently, these administrations elicited both innate and adaptive immune responses in the subjects. Notably, the observed immune responses and PK profiles exhibited variation contingent upon the phage type and the mammalian host. Despite these variations, the tested mammals exhibited a favorable tolerance to the IV-administered phages. This underscores the significance of comprehending these interactions for the optimization of phage therapy outcomes.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Key Laboratory of Quantitative Synthetic Biology, Shenzhen Institute of Synthetic Biology, Shenzhen Institutes of Advanced Technology, Chinese Academy of Sciences, Shenzhen, China.
- New Drug Evaluation Center of Shandong Academy of Pharmaceutical Sciences, Shandong Academy of Pharmaceutical Sciences, Jinan, China.
- Shandong Innovation Center of Engineered Bacteriophage Therapeutics, Jinan, China.
- Shanghai Key Laboratory for Nucleic Acid Chemistry and Nanomedicine, Institute of Molecular Medicine, State Key Laboratory of Oncogenes and Related Genes, Shanghai Cancer Institute, Renji Hospital, School of Medicine, S…
ORCID-Profile: Xin Tan, Yingfei Ma
Förderung
- The Ministry of Science and Technology of China, National Key R&D Program of China
- Shenzhen Medical Academy of Research and Translation fundings
- Shenzhen Institute of Synthetic Biology Scientific Research Program
- National Natural Science Foundation of China
- Shenzhen Outstanding Scientific Innovation Talents Training Project
- Programs Foundation of 20 articles for colleges and universities in Jinan
Zitieren
APA
Tan, X., Chen, K., Jiang, Z., Liu, Z., Wang, S., Ying, Y., Zhang, J., Yuan, S., Huang, Z., Gao, R., Zhao, M., Weng, A., Yang, Y., Luo, H., Zhang, D., & Ma, Y. (2024). Evaluation of the impact of repeated intravenous phage doses on mammalian host–phage interactions. Journal of Virology. https://doi.org/10.1128/jvi.01359-23
Vancouver
Tan X, Chen K, Jiang Z, Liu Z, Wang S, Ying Y, et al. Evaluation of the impact of repeated intravenous phage doses on mammalian host–phage interactions. Journal of Virology. 2024. doi:10.1128/jvi.01359-23
BibTeX
@article{Tan2024,
author = {Tan, Xin and Chen, Kai and Jiang, Zhihuan and Liu, Ziqiang and Wang, Siyun and Ying, Yong and Zhang, Jieqiong and Yuan, Shengjian and Huang, Zhipeng and Gao, Ruyue and Zhao, Min and Weng, Aoting and Yang, Yongqing and Luo, Huilong and Zhang, Daizhou and Ma, Yingfei},
title = {Evaluation of the impact of repeated intravenous phage doses on mammalian host–phage interactions},
journal = {Journal of Virology},
year = {2024},
doi = {10.1128/jvi.01359-23}
}
EUVIMED